Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · second_quarter · Q2
Comment on NIH Disease Prevention Strategic Plan
Kidney dialysis provisions in the American Tax Payers Relief Act
Source: Senate LDA
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Kidney Care Quality and Education Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Charlie W. Norwood Living Organ Donation Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
Kidney Disease Educational Benefits Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
Living Kidney Organ Donation Clarification Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
Kidney Care Quality and Education Act of 2007
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Implementation of the Patient Protection and Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · first_quarter · Q1
Design and implementation of the Patient Protection and Affordable Care Act
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · fourth_quarter · Q4
Integrated care delivery demonstration project for Medicare beneficiaries with chronic kidney disease.
Initiatives to increase deceased donor organ transplantation; to facilitate living organ donor transplantation; and, address quality of care issues for organ transplantation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · third_quarter · Q3
Comments on reimbursement for Intradialytic Parenteral Nutrition.
Design and implementation of the Patient Protection and Affordable Care Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · second_quarter · Q2
Design and implementation of the Patient Protection and Affordable Care Act.
Implementation of chronic kidney disease and end stage renal disease provisions in the Medicare Improvement for Patients and Providers Act of 2008
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · first_quarter · Q1
Sent letter questioning Medicare plans to change health information systems for ESRD care.
Submitted comments on AHRQ report on screening and treatment for Hepatitis C
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Economic Council (NEC), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · fourth_quarter · Q4
Initiatives to increase deceased donor organ transplantation, facilitate living organ donor transplantation, address international transplantation issues, and address quality of care issues for transplantation.
Reimbursement for dialysis services.
Comments regarding proposed changes in Clinical Laboratory Improvement Amendments.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · third_quarter · Q3
Comments regarding coverage for weight loss interventions
Comments regarding participation of nephrologists and dialysis clinics in "meaningful use" for Health Information Technology.
Comments regarding additives for meat and poultry.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · second_quarter · Q2
Design and implementation of various provisions of the Patient Protection and Affordable Care Act, specifically as it applies to individuals with chronic kidney disease
Comment letter regarding Nutrition Labeling of menu items in restaurants
Comment letter regarding methods for assuring access for covered Medicaid services
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · first_quarter · Q1
Medicare Hospital Inpatient Value-based Purchasing Program measures.
Comments on lifestyle interventions for Type 2 diabetes
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · fourth_quarter · Q4
Comments concerning Leading Health Indicators for Healthy People 2020.
Comments on Medicare Physician Compare Website
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · third_quarter · Q3
Comments on Comparative Effectiveness Research.
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comments on disclosure of nutrient content by chain restaurants.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · second_quarter · Q2
Response to proposal by the Department of Veterans' Affairs to change payment policy for kidney dialysis services
Comments on Conditions for Coverage for amublatory surgical centers
Allow physician assistants and nurse practitioners to order respiratory and rehabilitation services in a hospital setting
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · first_quarter · Q1
Discussion to establish Medicaid coverage of an education program for Stage 4 chronic kidney disease patients
Comments on Diabetes Research Strategic Plan
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · fourth_quarter · Q4
FY 2010 appropriations for the Indian Health Service
Submitted comments on regulations to implement amendments to the Americans with Disabilities Act
Recommend that Healthy People 2020 address the relationship between chronic kidney disease, diabetes, and cardiovascular disease, and address the disproportionate burden of kidney disease among members of ethnic and racial minority groups.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · third_quarter · Q3
Nutrition labeling for chronic kidney disease patients to monitor dietary calcium and potassium intake
FY 2010 appropriations for the Office of Minority Health to support expansion of a National Kidney Foundation program for detection of chronic kidney disease in high-risk populations
S 565 / HR 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · second_quarter · Q2
S. 565 / H.R. 1458, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Comments to Senate Finance Committee regarding health care reform
FY 2010 appropriations for Office of Minority Health to support expansion of a National Kidney Foundation program for detection of chronic kidney disease in high-risk populations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · first_quarter · Q1
Legislative and agency initiatives to increase organ donation for transplantation.
Comments to Centers for Medicare and Medicaid Services for Medicare Advantage and Part D plans requirements for participation in 2010.
FY 2010 appropriations for Office of Minority Health funding to support expansion of National Kidney Foundation screening program for detection of chronic kidney disease in at-risk populations.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · fourth_quarter · Q4
FY 2009 appropriations through Office of Minority Health to support expansion of the National Kidney Foundation Kidney Early Evaluation Program for detection of kidney disease in at-risk populations.
Implementation of Conditions of Coverage for end stage renal disease (ESRD) facilities.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · third_quarter · Q3
Comments to proposed update to Physician Fee Schedule as it relates to payment to physicians for organ retrieval.
FY 2009 appropriations through HHS Office of Minority Health to support expansion of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) kidney disease detection program.
Letter to FDA regarding sodium labeling and chronic kidney disease.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · second_quarter · Q2
Add potassium and calcium content as a required disclosure on nutrition panel of food labels.
FY 2009 funding through HHS Office of Minority Health to support expansion of the National Kidney Foundation's Kidney Early Evaluation Program kidney disease screening (KEEP) in locations with high percentages of at-risk minority populations.
Off Label use of drugs.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · first_quarter · Q1
Add Potassium as a required disclosure on nutrition labels
FY 2009 Appropriations for the Food and Drug Administration
FY 2009 funding through HHS Office of Minority Health to support expansion of the NKF Kidney Early Evaluation Program (KEEP) kidney disease screening program in locations with high percentages of at-risk minority populations.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · year_end · YY
Add Potassium as a required disclosure on nutrition labels.
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · mid_year · MM
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2005 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2005 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2004 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2004 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2002 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2001 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2000 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2000 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
1999 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
1999 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Recommendations on the future role of ESRD (end stage renal disease) Networks
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Payment for treatment of health outcomes that result from dialysis care, under Proposed Rule for Hospital Inpatient Prospective Payment System.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
End Stage Renal Disease Clincial Performance Measures Program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Office of Management & Budget (OMB), SENATE
* Inclusion of chronic kidney disease in Healthy People 2020 guideline. Medicare coverage of erythropoiesis stimulating agents (ESA's) for individuals with chronic kidney disease or chronic kidney failure. FDA labeling issues related to ESA's. Inclusion of chronic kidney disease in Healthy People 2020 guideline.
* Annual appropriations for Food and Drug Administration Funding for organ donation programs under the Health Resources and Services Administration. Annual appropriations for Food and Drug Administration
FY 2008 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Add Potassium as a required disclosure on nutrition labels.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE